Silence Therapeutics (SLN) Short Interest Ratio & Short Volume → A letter is coming from the 'Bureau of the Fiscal Service'. (From Stansberry Research) (Ad) Free SLN Stock Alerts $23.00 +0.06 (+0.26%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Silence Therapeutics Short Interest DataCurrent Short Volume297,200 sharesPrevious Short Volume145,700 sharesChange Vs. Previous Month+103.98%Dollar Volume Sold Short$6.50 millionShort Interest Ratio / Days to Cover1.3Last Record DateApril 30, 2024Outstanding Shares29,930,000 sharesPercentage of Shares Shorted0.99%Today's Trading Volume121,162 sharesAverage Trading Volume218,579 sharesToday's Volume Vs. Average55% Short Selling Silence Therapeutics ? Sign up to receive the latest short interest report for Silence Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSLN Short Interest Over TimeSLN Days to Cover Over TimeSLN Percentage of Float Shorted Over Time Ad InvestorPlaceHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs Silence Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024297,200 shares $6.50 million +104.0%N/A1.3 $21.86 4/15/2024145,700 shares $3.01 million -10.1%N/A0.6 $20.66 3/31/2024162,000 shares $3.50 million +74.8%N/A0.7 $21.60 3/15/202492,700 shares $2.12 million +100.7%N/A0.4 $22.84 2/29/202446,200 shares $1.18 million +31.6%N/A0.2 $25.47 2/15/202435,100 shares $768,339.00 -76.9%N/A0.2 $21.89 Get the Latest News and Ratings for SLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024152,200 shares $3.43 million +6.7%N/A0.9 $22.51 1/15/2024142,700 shares $2.53 million +7.9%N/A1.3 $17.70 12/31/2023132,200 shares $2.30 million +1.0%N/A1.7 $17.37 12/15/2023130,900 shares $2.10 million -7.8%N/A2.3 $16.03 11/30/2023141,900 shares $1.83 million +1.0%N/A3.1 $12.87 11/15/2023140,500 shares $1.32 million +4.1%N/A2 $9.39 10/31/2023135,000 shares $904,500.00 -3.6%N/A2.2 $6.70 10/15/2023140,000 shares $1.09 million +3.1%N/A2.1 $7.76 9/30/2023135,800 shares $1.33 million +5.0%N/A2.1 $9.82 9/15/2023129,400 shares $1.29 million +7.9%N/A1.9 $9.95 8/31/2023119,900 shares $1.07 million -4.2%N/A1.3 $8.90 8/15/2023125,100 shares $800,640.00 +24.0%N/A2.2 $6.40 7/31/2023100,900 shares $601,364.00 +41.3%0.4%1.5 $5.96 7/15/202371,400 shares $414,120.00 +349.1%0.3%1 $5.80 6/30/202315,900 shares $87,450.00 +52.9%0.1%0.2 $5.50 6/15/202310,400 shares $63,752.00 +7.2%0.0%0.1 $6.13 5/31/20239,700 shares $51,507.00 -56.7%0.0%0.1 $5.31 5/15/202322,400 shares $131,488.00 -36.7%0.1%0.3 $5.87 4/30/202335,400 shares $237,180.00 +91.4%0.1%0.6 $6.70 4/15/202318,500 shares $114,700.00 +30.3%0.1%0.3 $6.20 3/31/202314,200 shares $88,040.00 +11.8%0.1%0.4 $6.20 3/15/202312,700 shares $116,332.00 -12.4%0.0%0.3 $9.16 2/28/202314,500 shares $169,940.00 -17.1%0.1%0.3 $11.72 2/15/202317,500 shares $226,275.00 -22.2%0.1%0.5 $12.93 1/31/202322,500 shares $292,500.00 -2.6%0.1%0.7 $13.00 1/15/202323,100 shares $328,944.00 -24.3%0.1%0.7 $14.24 12/30/202230,500 shares $465,125.00 -23.9%0.1%0.9 $15.25 12/15/202240,100 shares $571,425.00 +28.9%0.1%1 $14.25 11/30/202231,100 shares $487,648.00 +16.5%0.1%0.7 $15.68 11/15/202226,700 shares $368,193.00 +24.2%0.1%0.6 $13.79 10/31/202221,500 shares $247,680.00 -30.7%0.1%0.4 $11.52 10/15/202231,000 shares $331,700.00 -8.3%0.1%0.5 $10.70 9/30/202233,800 shares $339,014.00 +39.7%0.1%0.6 $10.03 9/15/202224,200 shares $310,728.00 +50.3%0.1%0.4 $12.84Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. SLN Short Interest - Frequently Asked Questions What is Silence Therapeutics' current short interest? Short interest is the volume of Silence Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 297,200 shares of SLN short. Learn More on Silence Therapeutics' current short interest. What is a good short interest ratio for Silence Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLN shares currently have a short interest ratio of 1.0. Learn More on Silence Therapeutics's short interest ratio. Is Silence Therapeutics' short interest increasing or decreasing? Silence Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 297,200 shares, an increase of 104.0% from the previous total of 145,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Silence Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Silence Therapeutics: Savara Inc (6.37%), Lyell Immunopharma, Inc. (16.91%), Mineralys Therapeutics, Inc. (4.46%), Pharming Group (0.01%), ORIC Pharmaceuticals, Inc. (15.19%), Phathom Pharmaceuticals, Inc. (41.92%), Stoke Therapeutics, Inc. (15.94%), Calliditas Therapeutics AB (publ) (0.03%), GH Research PLC (5.05%), Avid Bioservices, Inc. (17.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Silence Therapeutics stock? Short selling SLN is an investing strategy that aims to generate trading profit from Silence Therapeutics as its price is falling. SLN shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Silence Therapeutics? A short squeeze for Silence Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLN, which in turn drives the price of the stock up even further. How often is Silence Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Savara Short Interest Lyell Immunopharma Short Interest Mineralys Therapeutics Short Interest Pharming Group Short Interest ORIC Pharmaceuticals Short Interest Phathom Pharmaceuticals Short Interest Stoke Therapeutics Short Interest Calliditas Therapeutics AB (publ) Short Interest GH Research Short Interest Avid Bioservices Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchElon’s New Device is About to Shock the WorldInvestorPlaceMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits